Wendy Diller

Senior Writer/Market Analyst

20 Years of Experience

About

Wendy writes on the medical devices and clinical diagnostics sectors, where she focuses on orthopedics/spine, molecular diagnostics and personalized medicine, clinical genomics, womens’ health/ femtech, and reimbursement/commercial strategy and innovation related to these specialties. She welcomes and encourages ideas and input from members of the MedTech Strategist Community.

Her career spans more than 20+ years as a top writer and manager focused on qualitative analysis of the global life sciences industry. She is Chair of Young Women in Bio Metro NY, an organization devoted to encouraging secondary students in the NY area to pursuit STEM careers and on the board of the Columbia Business School of Alumni Club NY

Specialties
Publications
Articles from Wendy Diller:
Read all from this author
Business Strategies

Personalized Medicine is Coming to Chronic Low Back Pain

  • 2026-03-23 00:00:00.0
  • Wendy Diller
  • MedTech Strategist

Low back pain, one of the most prevalent chronic conditions, is in the early stages of moving toward a more stratified, personalized model of care. Large spine companies remain focused on their core, one-size-fits-all businesses, while advances in scientific understanding of pain and technology are creating opportunities for new entrants like Aclarion, Persica Pharma, and Boston Scientific. A first of its kind, the NIH Heal Initiative has laid the groundwork, even as it weathers funding cuts

Read Article